|
VIPAR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.45610000022035E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.57200000000013E-05 |
| Normal-vs-Stage2 |
3.630000E-02 |
| Normal-vs-Stage3 |
1.463770E-02 |
| Normal-vs-Stage4 |
9.248600E-01 |
| Stage1-vs-Stage2 |
4.259200E-01 |
| Stage1-vs-Stage3 |
7.511200E-01 |
| Stage1-vs-Stage4 |
1.193780E-01 |
| Stage2-vs-Stage3 |
5.570000E-01 |
| Stage2-vs-Stage4 |
1.674780E-01 |
| Stage3-vs-Stage4 |
1.783450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88569999995492E-06 |
| Normal-vs-AfricanAmerican |
4.031200E-04 |
| Normal-vs-Asian |
2.621000E-01 |
| Caucasian-vs-AfricanAmerican |
5.423200E-01 |
| Caucasian-vs-Asian |
4.926800E-01 |
| AfricanAmerican-vs-Asian |
4.564400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.63290000005012E-06 |
| Normal-vs-Female |
1.390110E-04 |
| Male-vs-Female |
3.583400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.108200E-02 |
| Normal-vs-Extreme_Weight |
1.442920E-03 |
| Normal-vs-Obese |
1.362090E-04 |
| Normal-vs-Extreme_Obese |
2.781600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.410000E-01 |
| Normal_Weight-vs-Obese |
1.160620E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.892800E-01 |
| Extreme_Weight-vs-Obese |
1.454230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.421400E-01 |
| Obese-vs-Extreme_Obese |
4.088800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.148300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.88220000047524E-07 |
| Normal-vs-Age(61-80Yrs) |
1.047570E-04 |
| Normal-vs-Age(81-100Yrs) |
2.978600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.506400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.242000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.068200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.225800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.635820E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.509200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.7940000009491E-08 |
| Normal-VS-Type2 PRCC |
2.596300E-02 |
| Normal-VS-KIRP CIMP |
7.062000E-01 |
| Normal-VS-Unclassified PRCC |
2.161700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.197700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.918600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.895600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.716030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.125900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.202300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.275700E-03 |
| Normal-vs-N1 |
6.579700E-02 |
| Normal-vs-N2 |
3.217700E-02 |
| N0-vs-N1 |
7.756800E-01 |
| N0-vs-N2 |
1.756110E-02 |
| N1-vs-N2 |
7.544100E-02 |
|
|
